Showing results (681-690 of 727) with videos related to

Sort By:
Pageof 73
Environmental Pollution (Barking, Essex : 1987)|December 15, 2020
Daily submicron particle doses received by populations living in different low- and middle-income countriesAntonio Pacitto, Luca Stabile, Lidia Morawska, et al.
European Urology|September 11, 2022
Efficacy and Safety of Darolutamide in Patients with Nonmetastatic Castration-resistant Prostate Cancer Stratified by Prostate-specific Antigen Doubling Time: Planned Subgroup Analysis of the Phase 3 ARAMIS TrialMartin Bögemann, Neal D Shore, Matthew R Smith, et al.
BMC Medicine|February 10, 2021
Poor cardiovascular health is associated with subclinical atherosclerosis in apparently healthy sub-Saharan African populations: an H3Africa AWI-Gen studyEngelbert A Nonterah, Nigel J Crowther, Abraham Oduro, et al.
Clinical Medicine Insights. Case Reports|September 18, 2015
Cytomegalovirus-induced Hemorrhagic Colitis in a Patient with Chronic Myeloid Leukemia (Chronic Phase) on Dasatinib as an Upfront TherapyMohamed A Yassin, Abdulqadir J Nashwan, Ashraf T Soliman, et al.
Blood Advances|August 31, 2021
A new murine Rpl5 (uL18) mutation provides a unique model of variably penetrant Diamond-Blackfan anemiaLei Yu, Philippe Lemay, Alexander Ludlow, et al.
European Journal of Cancer (Oxford, England : 1990)|June 30, 2026
Clinically relevant endpoints and quality-of-life outcomes with darolutamide in patients with metastatic hormone-sensitive prostate cancer: Analyses of the phase III ARASENS trialKarim Fizazi, Matthew R Smith, Maha Hussain, et al.
Plos One|January 30, 2025
Obesity phenotypes and dyslipidemia in adults from four African countries: An H3Africa AWI-Gen studyEngelbert A Nonterah, Godfred Agongo, Nigel J Crowther, et al.
Biorxiv : the Preprint Server for Biology|May 4, 2026
Participant engagement and feedback in microbiome projects: a case of AWI-Gen 2Claudine Nkera-Gutabara, Luicer A Ingasia Olubayo, Ovokeraye O Oduaran, et al.
Cancer Medicine|December 26, 2025
Effects of Prior Local Therapy by Radical Prostatectomy or Radiotherapy on the Efficacy and Quality of Life of Patients Treated With Darolutamide in ARAMISMatthias Saar, Karim Fizazi, Neal D Shore, et al.
Investigational New Drugs|August 29, 2020
Novel [l,2,4]triazolo[3,4-a]isoquinoline chalcones as new chemotherapeutic agents: Block IAP tyrosine kinase domain and induce both intrinsic and extrinsic pathways of apoptosisMagda F Mohamed, Farid M Sroor, Nada S Ibrahim, et al.
Pageof 73